Supreme Court Shields Generic Drug Makers from Patent Liability for Pharmacist Prescriptions
In a unanimous decision, the U.S. Supreme Court has ruled that generic pharmaceutical manufacturers, such as Hikma Pharmaceuticals USA, cannot be held liable for infringements of a branded manufacturer’s patents based on decisions made by doctors and pharmacies. The ruling came in the Hikma Pharmaceuticals USA v. Amarin Pharma Inc. case, where the central issue…